Court rejects AstraZeneca’s plea on diabetes drug patent
Court rejects AstraZeneca’s plea on diabetes drug patent The Delhi high court has rejected global pharma major AstraZeneca’s application seeking a restraining order against marketing of a blockbuster anti-diabetes drug Dapagliflozin by domestic companies. https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment